𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Abnormal Expression of the Retinoblastoma Gene in Ovarian Neoplasms and Correlation to P53 and K-ras Mutations

✍ Scribed by Robert R. Taylor; R.Ilona Linnoila; Joseph Gerardts; Michael G. Teneriello; John D. Nash; Robert C. Park; Michael J. Birrer

Book ID
115616630
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
507 KB
Volume
58
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FHIT andp53 gene abnormalities in bronch
FHIT andp53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations
✍ Marchetti, Antonio; Pellegrini, Silvia; Bertacca, Gloria; Buttitta, Fiamma; Gaet πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

Bronchioloalveolar carcinoma (BAC) is a particular type of adenocarcinoma of the lung which accounts for up to 9 per cent of pulmonary malignancies. The aetiology and pathogenesis of this unique neoplastic disease are still unclear. Three histological subtypes of BAC have been recognized: mucinous,

Comparative analysis of mutations in the
Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer
✍ Georgina Berrozpe; James Schaeffer; Miguel Angel Peinado; Francisco X. Real; Man πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 827 KB

Mutations in codon I 2 of K-ras occur in a high proportion of pancreatic cancer cases. Although there is evidence that p53 mutations also occur in this tumor, few studies have been reported to date and no comparison has been made of K-ras and p53 mutations in the same tissues. Single-strand conforma

Mutation analysis of p53, K-ras, and BRA
Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression
✍ Daniele Calistri; Claudia Rengucci; Ian Seymour; Arturo Lattuneddu; Anna maria P πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract Gene mutations in __APC__, __K‐ras__, and __p53__ are thought to be essential events for colorectal cancer development. Recent data seem to indicate that __K‐ras__ and __p53__ mutations rarely co‐exist in the same tumor, indicating that these alterations do not represent a synergistic e